{"id":3946,"date":"2017-08-13T11:10:59","date_gmt":"2017-08-13T11:10:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/2nd-world-congress-integrative-medicine\/"},"modified":"2026-02-17T11:43:11","modified_gmt":"2026-02-17T11:43:11","slug":"congres-medecine-integrative-hyperthermie","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/fr\/congres-medecine-integrative-hyperthermie\/","title":{"rendered":"2e Congr\u00e8s mondial de m\u00e9decine int\u00e9grative Prof.Dr. G. Fiorentini &#8211; pr\u00e9sentation hyperthermie"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/fr\/congres-medecine-integrative-hyperthermie\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/fr\/congres-medecine-integrative-hyperthermie\/\",\n      \"name\": \"Prof. Dr. Giammaria Fiorentini : Leadership Scientifique Mondial & \u00c9tudes mHT\",\n      \"description\": \"D\u00e9couvrez le portfolio clinique et les recherches en mHT (Electro-Hyperthermie Modul\u00e9e) du Prof. Dr. Giammaria Fiorentini. \u00c9tudes multicentriques sur le cancer du pancr\u00e9as et le glioblastome.\",\n      \"inLanguage\": \"fr-FR\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"publisher\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/fr\/congres-medecine-integrative-hyperthermie\/#fiorentini\" },\n      \"about\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/fr\/congres-medecine-integrative-hyperthermie\/#fiorentini\" },\n        { \"@type\": \"MedicalProcedure\", \"name\": \"\u00c9lectro-hyperthermie modul\u00e9e (mHT)\" }\n      ]\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/fr\/congres-medecine-integrative-hyperthermie\/#fiorentini\",\n      \"name\": \"Prof. Dr. Giammaria Fiorentini\",\n      \"jobTitle\": \"Membre du conseil consultatif scientifique (SRHO & SIIO), Membre de l'ESHO\",\n      \"sameAs\": [\n        \"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fiorentini+G\",\n        \"https:\/\/scholar.google.com\/scholar?q=Giammaria+Fiorentini\"\n      ],\n      \"knowsAbout\": [\"Hyperthermie oncologique\", \"Oncologie int\u00e9grative\", \"Recherche clinique mHT\"],\n      \"workExample\": [\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"Hyperthermie combin\u00e9e \u00e0 la chimioth\u00e9rapie vs chimioth\u00e9rapie seule chez les patients atteints d'un cancer du pancr\u00e9as avanc\u00e9 (2023)\",\n          \"identifier\": \"PMID: 37398545\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"\u00c9lectro-hyperthermie modul\u00e9e dans le cancer du pancr\u00e9as de stade III et IV : r\u00e9sultats sur 158 patients (2021)\",\n          \"identifier\": \"PMID: 34909400\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"La mHT dans le traitement int\u00e9gratif du cancer pour le glioblastome malin et l'astrocytome r\u00e9cidivants (2019)\",\n          \"identifier\": \"PMID: 30580645\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"Quo Vadis Hyperthermie Oncologique ? (2020)\",\n          \"identifier\": \"PMID: 33014841\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"\u00c9tude clinique de phase II sur les gliomes malins r\u00e9cidivants trait\u00e9s par \u00e9lecto-hyperthermie (2006)\",\n          \"identifier\": \"PMID: 17203754\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"L'\u00e9lectro-hyperthermie modul\u00e9e comme traitement palliatif : analyse de 106 patients (2019)\",\n          \"identifier\": \"PMID: 31561722\"\n        }\n      ]\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/\",\n      \"logo\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/Andromedic-Logo.jpg\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">Excellence mondiale en oncologie int\u00e9grative : ICIM Rome 2023<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">Partenariat scientifique avec le Prof. Dr Giammaria Fiorentini<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\">L&rsquo;\u00e9quipe <strong>Imunomedica<\/strong> (Dr Virgiliu Vlaescu George, <a style=\"color: #1a2a6c; text-decoration: underline;\" href=\"https:\/\/andromedichyperthermia.com\/cristian-gologan\/\">Cristian Gologan M.Sc<\/a>., <a style=\"color: #1a2a6c; text-decoration: underline;\" href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-veronica-iatan\/\">Dr Veronica Iatan<\/a>, Dr Laurentiu Broscaru) a particip\u00e9 au 2e Congr\u00e8s mondial de m\u00e9decine int\u00e9grative, consolidant les protocoles d&rsquo;hyperthermie oncologique au plus haut niveau mondial.<\/p>\n<\/header>\n<div style=\"display: flex; flex-wrap: wrap; justify-content: center; gap: 20px; margin-bottom: 50px; background: linear-gradient(135deg, #1a2a6c, #b21f1f); padding: 35px; border-radius: 15px; color: #fff; text-align: center; box-shadow: 0 10px 25px rgba(0,0,0,0.15);\">\n<div style=\"flex: 1; min-width: 200px;\"><span style=\"font-size: 45px; font-weight: 800; display: block;\">357<\/span><span style=\"text-transform: uppercase; font-size: 13px; letter-spacing: 1.5px; font-weight: 600;\">\u00c9tudes PubMed<\/span><\/div>\n<div style=\"flex: 1; min-width: 200px;\"><span style=\"font-size: 45px; font-weight: 800; display: block;\">20+<\/span><span style=\"text-transform: uppercase; font-size: 13px; letter-spacing: 1.5px; font-weight: 600;\">Types de cancer trait\u00e9s<\/span><\/div>\n<div style=\"flex: 1; min-width: 200px;\"><span style=\"font-size: 45px; font-weight: 800; display: block;\">ESHO<\/span><span style=\"text-transform: uppercase; font-size: 13px; letter-spacing: 1.5px; font-weight: 600;\">Expertise m\u00e9dicale d&rsquo;\u00e9lite<\/span><\/div>\n<\/div>\n<div style=\"display: flex; flex-direction: column; align-items: center; gap: 30px; margin-bottom: 50px;\">\n<div style=\"width: 100%; max-width: 850px; text-align: center;\">\n<p><img loading=\"lazy\" decoding=\"async\" width=\"799\" height=\"571\" class=\"wp-image-502\" style=\"width: 100%; border-radius: 15px; box-shadow: 0 8px 20px rgba(0,0,0,0.1);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023.jpg\" alt=\"\u00c9quipe Imunomedica Rome 2023 - hyperthermie oncologique\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023.jpg 799w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023-300x214.jpg 300w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023-768x549.jpg 768w\" sizes=\"auto, (max-width: 799px) 100vw, 799px\" \/><\/p>\n<p style=\"font-size: 14px; color: #666; margin-top: 10px; font-style: italic;\">Certification de l&rsquo;expertise clinique en hyperthermie \u2013 Cristian Gologan M.Sc.<\/p>\n<\/div>\n<div style=\"width: 100%; max-width: 850px; text-align: center;\">\n<p><img decoding=\"async\" class=\"wp-image-503\" style=\"width: 100%; border-radius: 15px; box-shadow: 0 8px 20px rgba(0,0,0,0.1);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/2nd-world-congress-of-integrative-medicine-and-health-rome-2023.jpg\" alt=\"2e Congr\u00e8s mondial Rome 2023\" title=\"\"><\/p>\n<p style=\"font-size: 14px; color: #666; margin-top: 10px; font-style: italic;\">Session pl\u00e9ni\u00e8re de l&rsquo;ICIM Rome \u2013 L&rsquo;avenir de la m\u00e9decine oncologique int\u00e9grative.<\/p>\n<\/div>\n<\/div>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; padding: 35px; border-radius: 15px; background-color: #f9f9f9;\">\n<h3 style=\"color: #1a2a6c; border-bottom: 3px solid #b21f1f; display: inline-block; padding-bottom: 5px; margin-bottom: 20px;\">Leadership scientifique mondial<\/h3>\n<p style=\"font-size: 17px; margin-bottom: 20px;\">Le <strong>Prof. Dr Giammaria Fiorentini<\/strong> est un membre prolifique de l&rsquo; <a style=\"color: #b21f1f; text-decoration: none; font-weight: bold;\" href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO (European Society for Hyperthermic Oncology)<\/a> et un membre actif du conseil scientifique consultatif (SAB) pour la <strong>SRHO<\/strong> et la <strong>SIIO<\/strong>. Notre collaboration directe garantit aux patients l&rsquo;acc\u00e8s \u00e0 des r\u00e9sultats cliniques valid\u00e9s par plus de 350 publications.<\/p>\n<div style=\"background: #1a2a6c; padding: 20px; border-radius: 10px; text-align: center;\"><a style=\"color: #fff; text-decoration: none; font-weight: 800; font-size: 18px;\" href=\"http:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/WS-G-Giorentini-20-sept-2023-room-9-Rome-hyperthermia-x-gologan.pdf\"> T\u00c9L\u00c9CHARGER : Revue clinique et rapports de cas (PDF)<\/a><\/div>\n<\/section>\n<div style=\"background: #f0f4f8; padding: 30px; border-radius: 15px; margin-bottom: 50px; text-align: center; border: 1px solid #d1d9e6;\">\n<h4 style=\"color: #1a2a6c; margin-bottom: 25px; text-transform: uppercase;\">M\u00e9canisme d&rsquo;action document\u00e9 dans les recherches du Prof. Fiorentini<\/h4>\n<div style=\"display: flex; flex-wrap: wrap; justify-content: space-around; align-items: center; gap: 20px; margin-top: 20px;\">\n<div style=\"flex: 1; min-width: 250px; background: #fff; padding: 20px; border-radius: 10px; border-top: 5px solid #b21f1f;\">\n<p><span style=\"font-size: 24px; display: block; margin-bottom: 10px;\"> 13.56 MHz<\/span><\/p>\n<p style=\"font-size: 14px; margin: 0;\"><b>S\u00e9lectivit\u00e9 :<\/b> Les ondes radio d\u00e9tectent les cellules malignes gr\u00e2ce \u00e0 leur conductivit\u00e9 \u00e9lectrique \u00e9lev\u00e9e.<\/p>\n<\/div>\n<div style=\"flex: 1; min-width: 250px; background: #fff; padding: 20px; border-radius: 10px; border-top: 5px solid #b21f1f;\">\n<p><span style=\"font-size: 24px; display: block; margin-bottom: 10px;\"> Stress thermique<\/span><\/p>\n<p style=\"font-size: 14px; margin: 0;\"><b>Apoptose :<\/b> La chaleur cibl\u00e9e induit la destruction des cellules canc\u00e9reuses sans affecter les tissus sains.<\/p>\n<\/div>\n<div style=\"flex: 1; min-width: 250px; background: #fff; padding: 20px; border-radius: 10px; border-top: 5px solid #b21f1f;\">\n<p><span style=\"font-size: 24px; display: block; margin-bottom: 10px;\">&#xfe0f; Immunit\u00e9<\/span><\/p>\n<p style=\"font-size: 14px; margin: 0;\"><b>Effet abscopal :<\/b> Pr\u00e9paration du syst\u00e8me immunitaire pour reconna\u00eetre et attaquer les cellules malignes syst\u00e9miques.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<h3 style=\"color: #1a2a6c; border-left: 6px solid #b21f1f; padding-left: 15px; margin-bottom: 30px;\">R\u00e9f\u00e9rences cliniques majeures : Prof. Giammaria Fiorentini<\/h3>\n<div style=\"display: grid; grid-gap: 20px;\">\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #fff; border-top: 4px solid #b21f1f;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2023] Hyperthermie combin\u00e9e \u00e0 la chimioth\u00e9rapie vs chimioth\u00e9rapie chez les patients atteints d&rsquo;un cancer du pancr\u00e9as avanc\u00e9.<\/strong><\/p>\n<p style=\"font-size: 15px;\">Une \u00e9tude comparative multicentrique d\u00e9montrant une augmentation de la survie m\u00e9diane de 9 \u00e0 20 mois gr\u00e2ce \u00e0 l&rsquo;int\u00e9gration de la mHT.<\/p>\n<p><small style=\"color: #666;\"><strong>Auteur : Fiorentini G<\/strong>, et al. | World J Clin Oncol. PMID : 37398545<\/small><\/p>\n<\/div>\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #fff; border-top: 4px solid #b21f1f;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2021] \u00c9lectro-hyperthermie modul\u00e9e dans le cancer du pancr\u00e9as de stades III et IV : R\u00e9sultats sur 158 patients.<\/strong><\/p>\n<p style=\"font-size: 15px;\">Analyse observationnelle sur l&rsquo;une des plus grandes cohortes de patients, confirmant le contr\u00f4le tumoral aux stades avanc\u00e9s.<\/p>\n<p><small style=\"color: #666;\"><strong>Auteur : Fiorentini G<\/strong>, et al. | World J Clin Oncol. PMID : 34909400<\/small><\/p>\n<\/div>\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #fff; border-top: 4px solid #b21f1f;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2019] mHT dans le traitement oncologique int\u00e9gratif du glioblastome malin et de l&rsquo;astrocytome r\u00e9cidivants.<\/strong><\/p>\n<p style=\"font-size: 15px;\">\u00c9tude multicentrique contr\u00f4l\u00e9e sur des patients pr\u00e9sentant des r\u00e9cidives c\u00e9r\u00e9brales, validant la s\u00e9curit\u00e9 et la prolongation de la vie.<\/p>\n<p><small style=\"color: #666;\"><strong>Auteur : Fiorentini G<\/strong>, et al. | Integr Cancer Ther. PMID : 30580645<\/small><\/p>\n<\/div>\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #f4f7f9; border-top: 4px solid #1a2a6c;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2020] Quo Vadis Hyperthermie Oncologique ?<\/strong><\/p>\n<p style=\"font-size: 15px;\">Revue fondamentale red\u00e9finissant l&rsquo;hyperthermie oncologique, soulignant la s\u00e9lectivit\u00e9 nanoscopique des cellules malignes.<\/p>\n<p><small style=\"color: #666;\"><strong>Co-auteur : Fiorentini G<\/strong> | Front Oncol. PMID : 33014841<\/small><\/p>\n<\/div>\n<\/div>\n<div style=\"text-align: center; margin-top: 40px; padding: 25px; border: 2px dashed #1a2a6c; border-radius: 10px; background-color: #fcfcfc;\">\n<p style=\"font-weight: bold; margin-bottom: 15px;\">Explorez l&rsquo;int\u00e9gralit\u00e9 du portefeuille de recherche du Prof. Fiorentini :<\/p>\n<p><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fiorentini+G\" target=\"_blank\" rel=\"noopener\">VOIR LES 357 R\u00c9SULTATS SUR PUBMED<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Excellence mondiale en oncologie int\u00e9grative : ICIM Rome 2023 Partenariat scientifique avec le Prof. Dr Giammaria Fiorentini L&rsquo;\u00e9quipe Imunomedica (Dr Virgiliu Vlaescu George, Cristian Gologan M.Sc., Dr Veronica Iatan, Dr Laurentiu Broscaru) a particip\u00e9 au 2e Congr\u00e8s mondial de m\u00e9decine int\u00e9grative, consolidant les protocoles d&rsquo;hyperthermie oncologique au plus haut niveau mondial. 357\u00c9tudes PubMed 20+Types de&hellip;<\/p>\n","protected":false},"author":1,"featured_media":2526,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3946","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/pages\/3946","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/comments?post=3946"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/pages\/3946\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/media\/2526"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/fr\/wp-json\/wp\/v2\/media?parent=3946"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}